Tag Archives: medical devices

Zeteo Biomedical Expands into Pulmonary Drug Delivery with AriesMR Active Dry Powder Inhaler

New ZTECH-P™ pulmonary platform provides active, propellant-free powder aerosolization without reliance on patient inspiratory effort and supports single- and dual-API combination products

AUSTIN, Texas, Sept. 15, 2026 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical LLC today announced the expansion of its ZTECH-P™ powder drug-delivery platform into pulmonary delivery with the introduction of AriesMR™, a reloadable active dry powder inhaler designed for controlled pulmonary administration of pharmaceutical powders without reliance on patient-generated inspiratory energy for powder aerosolization or the use of CFC/HFA propellants.

Image caption: AriesMR™ Active Dry Powder Inhaler.

Unlike conventional passive dry powder inhalers that depend substantially on a patient’s inspiratory effort to disperse and aerosolize a formulation, AriesMR uses an integrated mechanical energy source to actively aerosolize and deliver the powder. The orientation-independent platform provides configurable dose and aerosolization parameters that can be optimized with formulation and particle characteristics for pulmonary delivery.

“AriesMR extends technologies we have developed and refined for nasal powder delivery into a pulmonary platform designed around many of the same challenges our pharmaceutical partners face—dose control, formulation protection, combination-product development and scalable manufacturing,” said Timothy Sullivan, Founder and Chief Executive Officer of Zeteo Biomedical.

“Importantly, the technology provides active powder aerosolization without requiring either HFA propellants or the patient’s inspiratory effort as the primary energy source for powder dispersion.”

The platform provides pharmaceutical developers with another approach to pulmonary combination-product development at a time when the industry is evaluating new inhalation technologies, including propellant-free alternatives to conventional pressurized inhaler platforms.

AriesMR incorporates replaceable unit-dose powder cartridges in a compact, mechanically actuated device, with on-board storage for up to six cartridges and a removable and replaceable mouthpiece. The device requires no battery power and is designed to operate independently of device orientation.

The platform can support single-API and dual-API configurations, including architectures in which separate powder formulations are maintained within the primary packaging until the point of delivery. This capability may enable combination-product strategies where formulation compatibility, stability or other development considerations make conventional co-formulation difficult.

AriesMR is being developed as part of Zeteo’s integrated combination-product development platform, bringing together delivery-device engineering, formulation and particle optimization, unit-dose primary packaging, product characterization and manufacturing technology. The platform is designed to support programs from early feasibility and preclinical development through clinical translation and commercial scale-up.

The expansion into pulmonary delivery builds on Zeteo’s existing ZTECH-P™ and ZTECH-L™ platforms supporting nasal, nose-to-brain, ophthalmic, sublingual and other non-invasive routes of administration.

Sullivan will participate in the IPAC-RS 2026 Nasal Innovation Forum, September 16–17 in Jersey City, New Jersey, where Zeteo will present work involving its intranasal powder delivery technology and meet with pharmaceutical and drug-delivery developers.

“Many of the formulation, device, primary-container and manufacturing challenges encountered in nasal powder development have direct parallels in pulmonary combination-product development,” Sullivan added. “The Forum provides an opportunity to discuss how those capabilities can be applied across both routes and to explore pulmonary programs where an active, propellant-free powder delivery approach may offer advantages.”

Learn more: https://zeteobiomed.com/pulmonary-drug-delivery/

ABOUT ZETEO BIOMEDICAL

Zeteo Biomedical LLC is a Cedar Park, Texas-based drug delivery technology and combination-product development company. Zeteo develops configurable delivery platforms for powder and liquid formulations across nasal, pulmonary, ophthalmic, sublingual and other non-invasive routes of administration. The company’s capabilities integrate delivery-device engineering, primary packaging, formulation and product development, in vitro characterization, manufacturing technology and commercialization support. For more information, visit Zeteo Biomedical to learn more about the AriesMR™ active dry powder inhaler: https://zeteobiomed.com/

Media Contact: Cathy Diehl, zeteo@zeteobiomed.com

MULTIMEDIA

Image link for media: https://www.Send2Press.com/300dpi/26-0915-s2p-ariesmr-300dpi.webp

Image caption: AriesMR™ Active Dry Powder Inhaler

LOGO: https://zeteobiomed.com/wp-content/uploads/2026/09/ZeteoLogo-transparent.png

NEWS SOURCE: Zeteo Biomedical LLC

This press release was issued on behalf of the news source (Zeteo Biomedical LLC), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/zeteo-biomedical-expands-into-pulmonary-drug-delivery-with-ariesmr-active-dry-powder-inhaler/

Reintroducing a Proven Performer – the FENYX+ – Now with Greater Flow Rates and Dispense Volumes

SYOSSET, N.Y., Sept. 30, 2025 (SEND2PRESS NEWSWIRE) — Fluid Metering Inc. is proud to unveil the FENYX+, a next generation pump engineered to meet the growing demands of high-flow fluidic control. As the evolutionary successor to the original FENYX variable dispense pump, the FENYX+ delivers approximately 230% greater flow rates and dispense volumes, setting a new benchmark in chemical metering performance.

Image caption: Fluid Metering Inc. FENYX+.

The FENYX+ is designed for seamless integration and long-term reliability. Each pump is manufactured in accordance with stringent quality standards to ensure optimal performance from the outset. The pump assembly features precision engineered components to meet the most demanding operational standards.

Key Product Features:

CeramPump® valveless technology simplifies architecture by utilizing only one moving part in the fluid path.
Sapphire-hard ceramic internals provide exceptional durability and precision, ensuring non-contact dispensing for millions of cycles.
Self priming, dispensing and flushing functions- all with a single device.

“The FENYX+ represents the next chapter in our fluidic innovation story. Building on the proven success of our original FENYX, we’ve engineered a pump that doesn’t just meet today’s high-flow demands – it anticipates tomorrow’s challenges. With 230% greater flow rates and dispense volumes, the FENYX+ demonstrates our unwavering commitment to pushing the boundaries of what’s possible in precision fluid control. This isn’t just an upgrade; it’s our promise to continue leading the evolution of fluidic solutions in life sciences,” said Sean Madden, Vice President, Product & Marketing at Fluid Metering, Inc.

Learn more: https://www.fluidmetering.com/products/fenyx-plus

About Fluid Metering Inc.

Fluid Metering Inc. has been a leader in precision fluid control for over 65 years. Our commitment to innovation and quality continues with the launch of the FENYX+, setting a new benchmark for performance in the industry.

For more information, please contact us at pumps@fluidmetering.com.

IMAGE link for media: https://www.fluidmetering.com/hs-fs/hubfs/Images/Products/OEM/FENYX+%20-%20S_transparent.png?width=555&height=555&name=FENYX+%20-%20S_transparent.png

NEWS SOURCE: Fluid Metering Inc

This press release was issued on behalf of the news source (Fluid Metering Inc), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/reintroducing-a-proven-performer-the-fenyx-now-with-greater-flow-rates-and-dispense-volumes/

Zeteo Biomedical Secures Global Patents for Nasal and Ophthalmic Drug Delivery Device Innovations

CEDAR PARK, Texas, June 11, 2025 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical, a privately held biomedical device company, today announced the issuance of new patents in the United States and European Union for its advanced drug delivery technologies. The patents, titled “Cartridge Devices for Administration of a Medicament” (U.S. Patent No. 12329949) and “Hand-Operated Devices for Administration of a Medicament” (EU Patent No. 3946526), further strengthen Zeteo’s ZTech™ delivery platform portfolio for the administration of drugs and biologics via nasal, ophthalmic, and sublingual routes.

Image caption: Zeteo Biomedical.

These patented innovations advance Zeteo’s ZTech-L™ and ZTech-P™ delivery systems, which include both single-use disposable and multi-dose, cartridge-reloadable handheld devices. The platforms support the administration of therapeutics in both liquid and dry powder formulations, including vaccines, biologics, and specialty drugs. Nasal delivery, in particular, is emerging as a highly effective, non-invasive alternative for treating conditions such as pain, emesis, seizures, neurodegenerative and autoimmune disorders, infectious diseases, and bioterror threats.

“We are seeing increasing global demand for metered-dose nasal, ophthalmic, and sublingual delivery devices that are compact, intuitive, and suitable for self-administration,” said Timothy Sullivan, CEO of Zeteo Biomedical. “A unique feature that sets our device technology apart is its ability to function reliably in any physical orientation, making it ideal for medication delivery in both terrestrial and space-based microgravity environments. This capability opens exciting new frontiers for Zeteo including applications in space-based healthcare.”

Zeteo’s integrated delivery platforms and technical services streamline the development and commercial-scale production of patient-centric drug/device combination products for pharmaceutical and biotech partners. This focus on patient-friendly design improves treatment adherence and medical outcomes, while enhancing product differentiation and brand value for manufacturers.

Zeteo’s platform technologies are designed to meet the evolving demands of global and interstellar healthcare markets, delivering precision, performance, and portability for the next-generation of therapeutic drug/device combination products.

About Zeteo Biomedical LLC

Zeteo Biomedical is a Texas-based medical device company focused on the development and commercialization of advanced drug and biologic delivery systems. The company specializes in intranasal, ophthalmic, and sublingual delivery technologies designed to improve patient outcomes through precision dosing, portability, and ease of use. Zeteo’s proprietary platforms are supported by an extensive patent portfolio and a range of product development services tailored to accelerate time to market for pharmaceutical and biotech clients worldwide.

To learn more, visit https://zeteobiomed.com/.

MEDIA CONTACT:
Cathy Diehl
Zeteo Biomedical LLC
+(1) 512-614-0144
zeteo@zeteobiomed.com

*LOGO link for media: https://www.send2press.com/300dpi/20-1117s2p-zeteo-biomedical-300dpi.jpg

NEWS SOURCE: Zeteo Biomedical LLC

To view the original story, visit: https://www.send2press.com/wire/zeteo-biomedical-secures-global-patents-for-nasal-and-ophthalmic-drug-delivery-device-innovations/

Redox Therapeutics Signs Exclusive License Agreement with The Curators of the University of Missouri to Create Filtration Technology to Address Healthcare and Environmental Needs

PHILADELPHIA, Pa., April 29, 2025 (SEND2PRESS NEWSWIRE) — Redox Therapeutics announces the signing of an exclusive license agreement with The Curators of the University of Missouri acting by and through the Missouri University of Science and Technology (Missouri S&T) for a patented polymer nanoparticles technology designed for endotoxin removal from fluids such as water, protein solutions and plasma. Currently, it’s seeking partners in the healthcare and wastewater industries to bring this technology to the forefront of effective and affordable treatment for sepsis.

Image caption: Redox Therapeutics logo.

Sepsis is a leading cause of death. The World Health Organization reports that endotoxin is the main contributing factor in sepsis and septic shock, complex syndromes of multiorgan failure resulting in the annual death of more than 11 million people. And the Association of American Medical Colleges says that sepsis is the third leading cause of death in U.S. hospitals.

An abstract in the National Library of Medicine reports that despite all efforts of experimental and clinical research during the last three decades, the ability to positively influence course and outcome of the syndrome remains limited.

Redox Therapeutics is looking to close the therapeutic gap by developing a blood filtration system that features the licensed polymer nanoparticles, which proved to remove up to 100 percent endotoxin from water and protein solutions in experiments conducted at Missouri S&T and published in peer-reviewed industry journals.

It also seeks to address another area of global health concern – the presence of endotoxin in contaminated industrial and wastewater systems. The presence of endotoxin in food, water and manufactured biomedical drugs is a major concern for human health and safety.

Redox Therapeutics seeks to partner with water filtration industry leaders and implement the endotoxin removal technology in their product lines, so that it contributes to lowering the incidence of sepsis.

Leonard Neatu, MD, founder, president and CEO of Redox Therapeutics, says he’s excited to have the opportunity to license and bring to market this outstanding nanoparticle technology. He has more than 25 years of entrepreneurial experience in the healthcare industry and as an independent scientist is part of a collective effort to precipitate a major shift in understanding as it regards the human disease occurrence and healing process.

He adds that this technology is not only extremely effective in removing endotoxin, but it’s also cost-effective.

“We’re confident that this technology will help to save lives, many of them, and I’m grateful for having the opportunity to contribute to this prospect,” he says.

Kamal H. Khayat, Vice Chancellor for Research and Innovation at Missouri S&T, looks forward to a long and successful relationship with Redox Therapeutics (Redox).

“S&T is thrilled to license this nanoparticle filtration technology to Redox so that its benefits can be used to help society,” he says.

About Redox Therapeutics, Inc.

Redox Therapeutics, Inc. is a biomedical technology startup company founded by Dr. Leonard Neatu, whose work is focused on the field of redox biology and its implications in the development and progression of diseases. The company’s mission is to translate the intellectual property, acquired over 10 years of integrative research, into the development and manufacturing of a series of filtration devices that aim to restore homeostasis in biological systems through complex and innovative treatments of plasma and cerebrospinal fluid.

About Missouri S&T

Missouri University of Science and Technology (Missouri S&T) is a STEM-focused research university of over 7,000 students located in Rolla, Missouri. Part of the four-campus University of Missouri System, Missouri S&T offers over 100 degrees in 40 areas of study and is among the nation’s top public universities for salary impact, according to the Wall Street Journal.

MORE INFORMATION

Redox Therapeutics: https://redoxtherapeutics.com/

Missouri University of Science and Technology: https://www.mst.edu/

Pain Neuromodulation Market to Reach $6.5 Billion by 2030

The market includes spinal cord stimulation (SCS) systems as well as peripheral nerve stimulation (PNS) systems

SAN FRANCISCO, Calif., March 31, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the newsletter Neurotech Business Report, announced the availability of a new market research report that forecasts the growth of the worldwide market for implanted pain neuromodulation systems. According to the newly published report, “The Market for Implanted Pain Neuromodulation Systems: 2025-2030,” the worldwide market will be $3.37 billion in 2025, growing to $6.49 billion by 2030, which represents a 12% compound annual growth rate. The market includes spinal cord stimulation (SCS) systems as well as peripheral nerve stimulation (PNS) systems. Neurotech Reports estimates that the PNS market will grow at a 29% CAGR between 2025 and 2030.

Image caption: Neurotech Reports recently released its latest forecast on the growth of the market for implanted pain neuromodulation systems, which include spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) systems.

Major players in the SCS market include Medtronic, Abbott, Boston Scientific, and Nevro, which was recently acquired by medtech manufacturer Globus Medical. The report includes Neurotech Reports editors’ analysis of the impact of this transaction on the competitive landscape of the SCS market. Newer players in the SCS market include Saluda Medical, which pioneered the concept of closed-loop SCS, and European firm Biotronik.

Leading competitors in the PNS space include Curonix, which markets an injectable pain stimulator, SPR, which markets a percutaneous system, Nalu Medical, Bioventus, and Mainstay Medical, which markets a restorative neuromodulation system for treatment of back pain of mechanical origin. Several startup and emerging firms are poised to enter the space in coming years.

The Market for Implanted Pain Neuromodulation Systems: 2025-2030 was authored by the editors of Neurotech Reports, including James Cavuoto, Jeremy Koff, Victor Pikov, and others. Now in its 25th year of publishing, Neurotech Reports is the longest-serving publishing and market-intelligence firm serving the neuromodulation market.

The report includes up-to-date information obtained at the 2025 meeting of the North American Neuromodulation Society, the 2025 JP Morgan Healthcare Conference, and other recent events. Data for the report was obtained from dozens of confidential interviews with key executives in the industry as well as numerous implanters of neuromodulation devices.

“There are a number of market research reports that claim to offer insight on the neuromodulation industry. But neuromodulation industry professionals should ask if they’ve ever seen the authors of those reports at key conferences such as NANS, INS, LSI. Neurotech Reports editors have been covering these events for 25 years and know the key players inside and out,” said James Cavuoto, editor and publisher of Neurotech Reports. “This report draws on our 25 years of reporting on the neuromodulation industry.”

Learn more: https://www.neurotechreports.com/pages/mnmsumm.html

MULTIMEDIA:

Image link for media: https://www.Send2Press.com/300dpi/25-0331-s2p-nrpainmod-300dpi.jpg

NEWS SOURCE: Neurotech Reports

This press release was issued on behalf of the news source (Neurotech Reports), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/pain-neuromodulation-market-to-reach-6-5-billion-by-2030/

Zeteo Biomedical Introduces CygnusMR™ and CygnusSDX™ Delivery Devices for Nasal Administration of Dry Powder Drugs and Biologics

Innovative Needle-Free Nasal Powder Delivery Systems Enhance Drug and Vaccine Development

CEDAR PARK, Texas, Feb. 19, 2025 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical LLC today announced the launch of its ZTech-P CygnusMR™ and CygnusSDX™ delivery devices, designed for precise, metered-unit dosing of dry powder drugs and biologics via systemic nasal and nose-to-brain administration. These innovative needle-free delivery systems provide pharmaceutical and biotech companies with advanced solutions to accelerate the development, clinical evaluation, and commercial deployment of dry powder nasal combination products for a broad range of therapeutic applications.

Image Caption: Zeteo Biomedical Introduces CygnusMR™ and CygnusSDX™ Delivery Devices for Nasal Administration of Dry Powder Drugs and Biologics.

Intranasal dry powder formulations offer significant advantages, including enhanced stability, extended shelf life, and improved bioavailability. Systemic nasal administration enables rapid, needle-free drug uptake, while nose-to-brain delivery bypasses the blood-brain barrier, allowing direct therapeutic access to the brain. The CygnusMR and CygnusSDX devices are designed for both patient self-administration and caregiver-assisted use, with configurations available for both adult and pediatric patients as well as a variety of animal species.

“The CygnusMR nasal delivery device is the industry’s first cartridge-reloadable nasal powder delivery system, featuring onboard storage for up to six unit doses and a replaceable nasal tip,” said Timothy Sullivan, CEO of Zeteo Biomedical. “Both the CygnusMR and CygnusSDX devices have undergone extensive analytical and in-vivo preclinical testing over the past several years to ensure optimal performance and reliability.”

Zeteo’s intranasal delivery devices leverage proprietary packaging technology that utilizes a Form Fill Seal (FFS) flexible foil blister system, eliminating the supply chain constraints associated with traditional drug packaging methods such as syringes and glass vials. This innovative approach provides superior protection for pharmaceuticals and biologics while allowing for storage under room temperature, refrigerated, or frozen conditions. The scalable ZTech FFS packaging platform enables the high-volume production of millions of doses per day—a critical capability for the rapid, cost-effective deployment of vaccines and medical countermeasures on a global scale.

Learn more: https://zeteobiomed.com/intranasal-drug-delivery/

About Zeteo Biomedical LLC:

Zeteo Biomedical™ is a leading biomedical device technology company headquartered in Cedar Park, Texas. The company provides novel technology and technical services supporting the development and commercialization of drug/device combination products, and fill/finish packaging solutions for pharmaceuticals, biopharmaceuticals, biologics, and botanicals. Zeteo’s technology applications include drug/device combination products for intranasal, nose-to-brain, ophthalmic, sublingual, and animal care applications. For more information please visit the Zeteo website at: https://www.zeteobiomed.com/.

IMAGE link for media: https://www.Send2Press.com/300dpi/25-0219-s2p-zeteo-nasal-300dpi.jpg

Image Caption: Zeteo Biomedical Introduces CygnusMR™ and CygnusSDX™ Delivery Devices for Nasal Administration of Dry Powder Drugs and Biologics.

NEWS SOURCE: Zeteo Biomedical LLC

To view the original story, visit: https://www.send2press.com/wire/zeteo-biomedical-introduces-cygnusmr-and-cygnussdx-delivery-devices-for-nasal-administration-of-dry-powder-drugs-and-biologics/

Mopec Group Unveils Next-Generation Maestro Grossing Station: The Mopec Maestro Encore

MADISON HEIGHTS, Mich. /ScoopCloud/ -- Mopec Group, a leading pathology technology company and manufacturer anatomic pathology equipment & supplies, is proud to announce the launch of the Mopec Maestro Encore, the latest advancement in grossing station technology. This release marks a significant milestone in Mopec Group's strategic effort to emphasize innovation and integration of cutting-edge digital solutions as the standard for improving pathology workflow.

The Mopec Maestro Encore now features Mopec's state-of-the-art digital pathology solution, PathCam, as a standard inclusion in every unit. PathCam boasts automated image enhancement, seamless integration with laboratory information systems (LIS), and advanced annotation capabilities. Additionally, Mopec PathCam(r) is designed to for frictionless integration with the leading Electronic Health Record (EHR) system. The Encore's hardware integration lays the groundwork for future developments in incorporating AI technology into Mopec's digital pathology platform, further solidifying the company's commitment to technological innovation.

"We are excited to introduce the Maestro Encore as the new benchmark in grossing station technology," said Francis X. Dirksmeier, CEO of Mopec Group. "This product embodies our mission to empower pathology and anatomy professionals with the leading platform of products and solutions for the advancement of diagnostic accuracy, safety, research, education, and the treatment of disease."

The Maestro Encore also features the patented SafeDraft(tm) Ventilation Technology, which directs air from the cutting surface's front to the back, establishing a laminar flow pattern that enhances the effectiveness of the robust backdraft technology. This consistent ventilation is crucial in safeguarding users against potential hazardous formalin exposure.

Additionally, the new OrchestraOS introduces configurable notifications and alerts for everything from reduced airflow to filter replacements, ensuring user safety remains paramount. The easy-to-change Integrated Air Filtration System further optimizes airflow, mitigating and preventing formalin exposure risks.

"With the Maestro Encore, we are not just offering a high-quality piece of equipment; we are providing an integrated technology platform that enhances the entire pathology workflow," said Michael McClain, Vice President of Technology at Mopec Group. "This innovation is the first step towards a future where AI technology will revolutionize anatomic pathology workflow."

Jeff Pemberton, Vice President of Marketing & Commercial Strategy, added, "The Maestro Encore is a testament to Mopec Group's dedication to leading the industry with innovative, technology-driven solutions that prioritize both safety and efficiency. We are proud to continue supporting pathology professionals with the tools they need to achieve excellence in their work."

The Mopec Maestro Encore is now available for order. For more information, visit https://www.mopec.com/maestro or contact Mopec Group's sales team.

About Mopec:

As a division of Mopec Group, Mopec is guided by our mission to empower pathology & anatomy professionals with the leading platform of products and solutions for the advancement of diagnostic accuracy, safety, research, education, and the treatment of disease. This mission has driven us to become the leading experts on anatomic and forensic pathology equipment and workflow. We've been working hand-in-hand with pathology professions for over 30 years developing systems and solutions that facilitate safer gross examinations.

As anatomic pathology as evolved, Mopec Group has been at the forefront, getting feedback, improving design, and solving problems. Our unwavering dedication to excellence is underscored by the widespread installations within America's premier healthcare institutions, a testament to our continuous pursuit of providing cutting-edge tools that significantly contribute to the progress and safety of pathology and anatomy professionals worldwide. We are innovators. We are collaborators. We are grossing. Learn more: https://www.mopec.com/

Mopec Group, a leading pathology technology company and manufacturer anatomic pathology equipment & supplies, is proud to announce the launch of the Mopec Maestro Encore, the latest advancement in grossing station technology. This release marks a significant milestone in Mopec Group's strategic effort to emphasize innovation and integration of cutting-edge digital solutions as the standard for improving pathology workflow.

Related link: https://www.mopec.com/

Introducing the Cellular 2 Device: Soberlink’s Latest Advancement in Remote Alcohol Monitoring

HUNTINGTON BEACH, Calif. /ScoopCloud/ -- Introducing the new Cellular 2 Device, the latest addition to Soberlink's line of remote alcohol monitoring solutions. Designed with user convenience and global accessibility in mind, the Cellular 2 Device seamlessly combines a sleek design with comprehensive functionality, offering a dependable tool for individuals and professionals in Family Law, Addiction Recovery, and Workplace Compliance.

Enhanced Design and Global Connectivity

The new Cellular 2 Device builds upon the strengths of Soberlink's previous models, featuring a slimmer, more modern form factor and a superior battery life of 14+ days. With its built-in cellular module, the device ensures users can submit tests from anywhere in the world, connecting them to a network of global LTE coverage.

Reliable Test Storing Feature

A key feature that continues to distinguish the Cellular 2 Device is its reliable test storing function. In situations where cellular connectivity is unavailable, the Cellular 2 Device securely stores test data, proactively attempting to transmit stored tests until a connection is restored. This feature ensures that tests are recorded and reported accurately on Soberlink's Advanced Reporting. These calendar-format reports utilize AI to reconcile the time-stamped tests, accurately reflecting the time they were taken, rather than when they were transmitted. The consistent retention and precise reporting of tests during connectivity outages are crucial to Soberlink's commitment to reliability and earning the trust of users.

Simplified User Experience

Aiming to make alcohol monitoring even more straightforward and less intrusive, the Cellular 2 Device boasts an intuitive interface with an LED screen and simple navigation buttons. Enhanced by a device leveling feature that guides users to hold the device in a way that is optimal for built-in facial recognition, the Cellular 2 Device ensures an efficient and smooth user experience.

Testimonials from Cellular 2 Users

"I like the fact that I do not have to hold my cell phone up while taking my test. Makes everything much easier and user friendly."

"The Cellular 2 Device is wonderfully portable."

"It's much easier for travel."

"Thankfully, the device will store tests. Otherwise, I would be dead in the water."

"It is super easy to use... Been using it for a few weeks and only charged it once."

Recognition from Industry Professionals

The functionality and design of Soberlink's devices have garnered positive feedback from various sectors.

Nicola Donaldson, Certified Supervised Counselor, has praised the device, mentioning how, "Soberlink just ticked all the boxes in terms of convenience, portability, and user friendliness. We were really impressed with just how easy it all is."

Family Law professional Sean Wirth also recognizes the value of Soberlink, stating, "I trust [Soberlink] because it's an all-in-one device. You have the facial recognition built-in to a reliable breathalyzer device with real-time results. It just provides a great product for Family Law practitioners and clients."

Dedicated to Quality and Innovation

The Cellular 2, like all Soberlink devices, undergoes a meticulous design, development, testing, and manufacturing process in the United States. This dedication ensures that Soberlink continues to provide reliable, accurate, and high-quality solutions to support accountability for sobriety.

The introduction of the Cellular 2 Device marks a significant achievement as Soberlink strives to continue delivering enhanced and simplified experiences in remote alcohol monitoring. Soberlink invites you to explore the capabilities of the Cellular 2 Device.

Learn more: https://www.soberlink.com/cellular-alcohol-monitoring-device

About Soberlink:

Soberlink supports sobriety accountability with its alcohol monitoring system, combining professional-grade breathalyzers with cutting-edge connectivity. Trusted by professionals in addiction recovery, workplace compliance, and family law, Soberlink's solutions are designed to offer reliability, convenience, and peace of mind.

For additional information about the Cellular 2 Device and Soberlink's full range of products, please visit https://www.soberlink.com/.

MULTIMEDIA:

VIDEO (YouTube): https://youtu.be/U0y_YBYFQBk

Introducing the new Cellular 2 Device, the latest addition to Soberlink's line of remote alcohol monitoring solutions. Designed with user convenience and global accessibility in mind, the Cellular 2 Device seamlessly combines a sleek design with comprehensive functionality, offering a dependable tool for individuals and professionals in Family Law, Addiction Recovery, and Workplace Compliance.

Related link: https://www.soberlink.com/

Fluid Metering, Inc. Unveils FENYX: A Revolutionary Leap in Fluidic Precision

SYOSSET, N.Y. /ScoopCloud/ -- Fluid Metering Inc., a leading manufacturer of fluid control solutions, proudly announces the debut of its groundbreaking variable dispense pump, FENYX (patent pending), heralding a new era of fluidic precision. Crafted to meet the evolving needs of the life sciences field, the FENYX integrates an advanced miniaturized fluidic system, enabling precise control of microliter volumes across a wide spectrum of applications.

Not only does the FENYX variable dispense pump streamline flushing, priming, and dispensing into a single, cohesive unit, it also offers unmatched flexibility, allowing dispensing over various surfaces or wells through non-contact dispensing without requiring physical intervention. Pioneering components, such as a calibratable flag, anti-backlash mechanism, and encoder, address the escalating demand for heightened throughput, single microliter dispense volumes, and minimized downtime.

Harnessing Fluid Metering's renowned CeramPump(R) technology, the FENYX boasts a sleek, low-profile design, delivering the industry's expected levels of precision and accuracy even while dispensing over air. This breakthrough innovation is poised to redefine fluidic solutions within the diagnostic, biotechnology & medical device space, playing a pivotal role in achieving impactful outcomes.

"The FENYX isn't just a pump; it's a symbol of Fluid Metering's commitment to innovation and our relentless pursuit of excellence in fluidic solutions. The FENYX marks our bold entry into the variable dispense pump market, expanding our capabilities beyond fixed dispense pumps. Join us as we embark on this exciting journey towards shaping the future of fluidic precision in life sciences," said Sean Madden, Vice President, Commercial and Product Development at Fluid Metering Inc.

Learn more: https://www.fluidmetering.com/fenyx

About Fluid Metering Inc.:

Fluid Metering Inc. stands at the forefront of fluid control innovation, having revolutionized the industry with our patented valve-less rotating and reciprocating piston metering pump concept, providing unmatched pumping excellence and precise fluid control across Diagnostics, Biotechnology, and Medical Device applications. With over 60 years of OEM design experience, our engineering team is dedicated to meeting customer and application requirements with unparalleled accuracy, precision, and reliability.

Learn more at: https://www.fluidmetering.com/

Fluid Metering Inc., a leading manufacturer of fluid control solutions, proudly announces the debut of its groundbreaking variable dispense pump, FENYX (patent pending), heralding a new era of fluidic precision. Crafted to meet the evolving needs of the life sciences field, the FENYX integrates an advanced miniaturized fluidic system, enabling precise control of microliter volumes across a wide spectrum of applications.

Related link: https://www.fluidmetering.com/

Fluid Metering Announces New Distribution Partnership with Girtec AG

SYOSSET, N.Y. /ScoopCloud/ -- Fluid Metering Inc. (FMI) is pleased to announce that Switzerland-based Girtec AG was recently appointed a strategic distributor to cover sales of our ultra-precise fluid control metering and dispensing products in Germany, Switzerland, Austria, and Liechtenstein.

Girtec AG, founded in 2012, provides its fluidic products and services in the fields of medical, laboratory and analytical technology instrumentation while developing innovative reliable solutions in close cooperation with its customers.

"This recent distribution partnership is more than just a collaboration - it is the beginning of a groundbreaking era for first-class products and innovation in our market. This partnership not only brings outstanding products into the hands of our customers, but also sets a new benchmark for quality, reliability, and technological excellence. We proudly combine first-class products with our local presence to offer our customers unique added value," as stated by Christoph Girsberger, CEO and Owner at Girtec AG.

"We are excited about this strategic alliance between both organizations to help meet the growing demand for ultra precise microfluidic pumps for medical and life sciences applications within the region," as stated by Sean Madden, Vice President of Commercial and Product Development at Fluid Metering.

About Fluid Metering Inc.:

Fluid Metering, Inc. pioneered the first patented valveless rotating and reciprocating piston metering pump concept delivering pumping excellence and precise fluid control for OEM, Medical and Life Science applications. Fluid Metering's engineering team incorporates over 60 years of OEM design experience to meet specific customer and application requirements with Accuracy, Precision & Reliability!

Fluid Metering Inc. was established in 1959 and is headquartered in Syosset, New York.

Website: https://www.fluidmetering.com/

Fluid Metering Inc. (FMI) is pleased to announce that Switzerland-based Girtec AG was recently appointed a strategic distributor to cover sales of our ultra-precise fluid control metering and dispensing products in Germany, Switzerland, Austria, and Liechtenstein.

Related link: https://www.fluidmetering.com/

Mopec Announces Distribution Partnership with Nano Surgical to Offer Customers the Lumohs Lighted Scalpel Handles

MADISON HEIGHTS, Mich. /ScoopCloud/ -- Mopec, a leading manufacturer of anatomic pathology products, announced their new distributor partnership with Nano Surgical to become the exclusive master distributor of Lumohs Lighted Scalpel Handles in the pathology and laboratory markets.

Lumohs Lighted Scalpel Handles represent a cutting-edge solution for enhancing surgical instruments. This innovative product transforms surgical practices by providing shadowless, unobstructed illumination mere millimeters from the operating site, thereby mitigating potential risks associated with various medical procedures. This advancement guarantees improved visibility during complex processes, promoting a safer environment for surgeons, their team, and patients alike.

"At Mopec, we're always looking for innovative solutions that solve problems and empower anatomy and pathology professionals," said Jeff Pemberton, VP of Marketing and Consumables for Mopec. "When we found Lumohs, we recognized the value it brings and knew it was the perfect fit for our line of high quality dissection instruments and scalpel handles."

Lumohs features broad, rounded grips that effectively minimize neck, back, and wrist strain and fatigue associated with struggling to illuminate any surgical site. Driven by a replaceable battery cartridge, the portable and autoclavable handles are available in #3, #4, and #8 handles.

"We're very excited to partner with Mopec and launch our new #4 and #8 Lumohs handles specifically designed for their pathology and lab business," said Dr. Steven Hacker, Founder of Nano Surgical and Inventor of Lumohs. "These handles, along with our #3 handles, will provide Mopec the ability to meet all their customers' scalpel needs, including lab, anatomic, and forensic pathology segments."

With a handle designed for every specialist and compatibility with any blade size or brand, Lumohs becomes an indispensable tool for achieving optimal visibility and safety in any medical setting. These versatile tools not only ensure seamless adaptability, but also provide a cost-effective alternative for budget-conscious practices.

For more information or to obtain a quotation, please visit https://www.mopec.com/lumohs/, or call (800) 362-8491.

About Mopec:

As a division of Mopec Group, Mopec is guided by our mission to empower pathology & anatomy professionals with the leading platform of products and solutions for the advancement of diagnostic accuracy, safety, research, education, and the treatment of disease. This mission has driven us to become the leading experts on anatomic and forensic pathology equipment and workflow. We've been working hand-in-hand with pathology professions for over 30 years developing systems and solutions that facilitate safer gross examinations. As anatomic pathology has evolved, Mopec Group has been at the forefront, getting feedback, improving design, and solving problems. Our unwavering dedication to excellence is underscored by the widespread installations within America's premier healthcare institutions, a testament to our continuous pursuit of providing cutting-edge tools that significantly contribute to the progress and safety of pathology and anatomy professionals worldwide. We are innovators. We are collaborators. We are grossing.

Mopec, a leading manufacturer of anatomic pathology products, announced their new distributor partnership with Nano Surgical to become the exclusive master distributor of Lumohs Lighted Scalpel Handles in the pathology and laboratory markets.

Related link: https://www.mopec.com/

Neo-Bionica Appoints Uli Gommel As Chief Technology Officer

LOS ANGELES, Calif. /ScoopCloud/ -- Neo-Bionica, a leading innovator in the field of medical device development and manufacturing, is thrilled to announce the appointment of Uli Gommel as its new Chief Technology Officer (CTO). Uli will lead Neo-Bionica's technology division spearheading its mission to revolutionize the way that companies bring novel neurotechnologies and smart MedTech devices to market.

Uli Gommel joins Neo-Bionica as a global leader in medical engineering with two decades experience spanning Europe, Asia and the US. Prior to joining Neo-Bionica, he was the Director of Mechanical Engineering at Advanced Bionics. There he led the end-to-end development and launch of the HiResTM Ultra 3D Cochelar Implant, a groundbreaking device which won the MedTech Breakthrough Award in 2019 for best overall medical device solution. Uli's expertise also extends to the development of pediatric cochlear implants, specialized surgical tools and high-resolution implantable electrode arrays.

Based in the US and with a proven track record in growing global MedTech teams, Uli's appointment demonstrates Neo-Bionica's commitment to growing its US presence. As CTO of Neo-Bionica, Uli will oversee design, development, and manufacturing services, providing expert insights for clients developing next-generation neurotech and smart MedTech devices. Through an outstanding depth and breadth of bioengineering expertise, fabrication skills, and regulatory know-how, Uli's experience will help to accelerate the development of implantable and wearable neurotechnologies and bioelectronics devices.

"Neo-Bionica is pushing the boundaries of what is possible in the field of neurotechnology," said Uli. "I am honored to join this talented team and contribute to our shared vision of enhancing the lives of the people who will benefit from these products."

Neo-Bionica's CEO, Dr. Ludovic Labat, said "Not only does Uli's expertise and vision align perfectly with our mission to help companies realize the promise of bioelectric devices, but his presence in the US also signals our commitment to serving the needs of this significant market. With his leadership, Neo-Bionica will continue to grow quickly and smartly."

Uli will be leading a team of highly experienced industry and academic professionals with backgrounds in MedTech, mechanical and electronic engineering and previous experience from top-tier institutions including Invetech, Medtronic, Cochlear, Bionics Institute and Planet Innovation.

Neo-Bionica was established in 2021 to meet a need in the Australian market. Despite Australia's deep expertise in the development of advanced MedTech and Neurotech devices, emerging Australian Neurotech innovators were frequently forced to go overseas to prototype and manufacture their devices. Neo-Bionica was established to meet this gap in the market and since its establishment, its expertise and services have been in high demand from not only local innovators but international clients. Given this demand, Neo-Bionica fast-tracked its plan to establish a permanent foothold in the US with Uli's appointment.

About Neo-Bionica:

Neo-Bionica is an advanced Medtech manufacturer that specializes in providing commercialization and manufacturing services to develop digitally-enabled bionic and smart, neurotech medical device innovations. Neo-Bionica's expertise includes developing AI-powered devices designed to restore human function and smart sensors capable of intelligently monitoring human physiology.

Headquartered in Melbourne, Australia, Neo-Bionica has quickly gained recognition within the industry. Neo-Bionica is proud to be empowering the next generation of MedTech innovators with advanced manufacturing services. https://neo-bionica.com/

Neo-Bionica, a leading innovator in the field of medical device development and manufacturing, is thrilled to announce the appointment of Uli Gommel as its new Chief Technology Officer (CTO). Uli will lead Neo-Bionica's technology division spearheading its mission to revolutionize the way that companies bring novel neurotechnologies and smart MedTech devices to market.

Related link: https://neo-bionica.com/

Spine IEP Fellows & Young Surgeons’ Course Announces Premier Foundation Sponsor for its 2023 Course

SAN DIEGO, Calif. /ScoopCloud/ -- Magnifi Group, Inc., announced today its partnership with SI-BONE, Inc. as the Premier Foundation Sponsor for its 2023 Spine IEP Fellows & Young Surgeons' Course to be held in Atlanta, Georgia, November 17-19.

SI-BONE is a global leader in technology for the surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Since pioneering minimally invasive SI joint surgery in 2009, SI-BONE has supported over 3,000 surgeons in performing a total of over 80,000 sacropelvic procedures. A unique body of clinical evidence supports the use of SI-BONE's technologies, including two randomized controlled trials and over 120 peer-reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma.

As a returning sponsor to the Spine IEP Course, SI-BONE is committed to advancing the field of spine surgery through innovation, education, and collaboration with leading medical professionals.

Geoff Maw, SI-BONE Vice President of US Academic & Commercial Development said SI-BONE has a long history of dedicating time and resources to the next generation of spine surgeons.

"The Spine IEP Fellows & Young Surgeons' Course is an ideal setting in which SI-BONE can further support the education of young surgeons," Maw said. "We look forward to taking a leading role in our commitment to this important course," Maw added.

"The Spine IEP Course for Fellows & Young Surgeons, now in its 13th consecutive year, continues to educate attendees on the latest medical device techniques and biologics," said Dr. Frank Phillips, Spine IEP Course Chair and Director, Department of Orthopedic Surgery, Rush University Medical Center. "SI Bone has been an active participant at the Spine IEP Course for many years and we welcome the company's sustained commitment to Spine Fellows & Young Surgeons," Phillips said.

The Spine IEP Fellows & Young Surgeons' Course, is limited to 50-55 attendees in order to accommodate a didactics rotation schedule of 45-50 tables hosted by medical device and biologics companies. Four cadaver labs will also be offered during the duration of the course.

The interactive course has been specifically developed to educate spine and neurosurgery Fellows and Young Surgeons on current topics related to the practice of spine and neurosurgery, as well as to assist attendees with the transition from academics to practicing surgeons. The classroom format for the course is highly interactive and all sessions conclude with question/answer sessions and panel discussions.

According to Magnifi data, an average of 70-80 spine Fellows enter the US market each year as practicing spine surgeons. Of these, 48-50 Fellows & Young Surgeons are expected to attend the upcoming course.

Magnifi Group, Inc. is a developer of an FDA-compliant eLearning platform for the medical device and biologics industries. The company also hosts the Spine IEP Live Fellows Course; the Lower Extremity IEP Live Fellows Course and the Hip and Knee IEP Live Fellows Course.

Learn more: https://www.magnifigroup.com/

Magnifi Group, Inc., announced today its partnership with SI-BONE, Inc. as the Premier Foundation Sponsor for its 2023 Spine IEP Fellows & Young Surgeons' Course to be held in Atlanta, Georgia, November 17-19. SI-BONE is a global leader in technology for the surgical treatment of musculoskeletal disorders of the sacropelvic anatomy.

Related link: https://www.magnifigroup.com/

Mopec Announces Distribution Partnership with StatLab to Bring You the Best Cassette Printer in North America

MADISON HEIGHTS, Mich. /ScoopCloud/ -- Mopec, a leading manufacturer of anatomic pathology grossing stations, announced their new distributor partnership with StatLab to allow their customers the opportunity to purchase StatLab PiSmart Cassette Printers directly from Mopec.

Widely reviewed as the best cassette printer on the market, the StatLab PiSmart Cassette Printer is designed to improve accuracy, efficiency, and automation in your lab. This new partnership will simplify the process for customers looking to upgrade their grossing station expenditures with additional equipment and accessories.

"Mopec prides itself on building the safest and most advanced grossing stations and pathology equipment in the market," said Carmen Evola, CEO of Mopec. "If there's something we can't build, we're going to partner with someone who can. Mopec is thrilled to work with StatLab to help us provide our customers with a product we trust from a company we can rely on."

The PiSmart Cassette Printer is available in two models, the PiSmart Single Plus and the PiSmart Six. The PiSmart Single Plus is suitable for on-demand printing and can deliver the first printed cassette in under three seconds. The PiSmart Six offers more functionality with 6 cassette hoppers and can be used for on-demand or batch printing.

Both models feature a built-in scanner as well as an internal label design software allowing the printer to be used efficiently without the use of a PC. The true on-demand printing and small footprint makes the PiSmart Cassette Printer ideal for integrating seamlessly with the Mopec Maestro Grossing Station, giving customers unparalleled convenience and workflow optimization in their lab.

"Mopec was in search of a cassette printer that met the same quality and convenience our customers have grown accustomed to when ordering from Mopec," said Jeff Pemberton, Vice President of Marketing & Consumables. "We wanted to provide an option that would integrate well with our Maestro grossing stations and that we felt comfortable putting our reputation behind. StatLab's PiSmart was the obvious choice."

Along with the PiSmart Cassette Printers, Mopec is also adding Pi Cassettes to their Consumables lineup. Pi Cassettes are designed specifically for use on the PiSmart printer. They utilize a patented feature that both protects the printed surface during dewaxing, while still enabling the surface to be cleared of wax.

For more information or to obtain a quotation, please visit https://www.mopec.com/, or call (800) 362-8491.

About Mopec:

Mopec, based in Madison Heights, Michigan, is a manufacturer and distributor of high-quality pathology, anatomy, mortuary, and necropsy equipment and products. Founded in 1992, Mopec differentiates itself through its extensive engineering process, superior design, and market-leading quality. Mopec is Elevating Pathology and specializes in solutions for forensic and anatomic pathology labs in hospitals, universities, morgues, and a variety of other markets. Mopec is committed to the production innovative products and providing high quality customer service. For more information, visit https://www.mopec.com/.

Mopec, a leading manufacturer of anatomic pathology grossing stations, announced their new distributor partnership with StatLab to allow their customers the opportunity to purchase StatLab PiSmart Cassette Printers directly from Mopec.

Related link: https://www.mopec.com/

iRxReminder chooses CAREier for medical device support to empower patient population

POTOMAC, Md. /ScoopCloud/ -- iRxReminder, a medication monitoring platform service, recently teamed up with CAREier, the revolutionary medical device communication company, to ensure its patients remain safe and independent.

"We're thrilled that iRxReminder chose to partner with us to ensure they meet their mission to empower patients to greater stability and increase health agency revenue," Ryan Bass, CEO, CAREier says.

Anthony Sterns, founder, iRxReminder, first met Bass through the NewChip Accelerator Program which connects new and experienced investors to business and real estate investment opportunities around the nation.

"When our group shared what each of us was doing, I knew immediately that we needed CAREier's device information tracking and notification services to ensure we always had a way to manage devices should they ever need to be exchanged or recalled," Sterns says. "CAREier backs us up and gives us the ability to interact directly with customers and to act quickly as needed."

For example, if there's a manufacturer's component defect such as a motor fail in a specific lot of medical devices, CAREier is responsible for quick communication to those customers. It will also resolve the situation through a seamless medical device exchange.

"CAREier's software is exactly what we - and our customers need - for peace of mind when it comes to a fully functioning product to support their medications," Sterns adds.

About CAREier:

CAREier is revolutionizing medical device communications to finally include the patient. Its mission is to create a complete communication ecosystem between regulators, medical device manufacturers, healthcare providers, physicians and patients to transmit urgent messages in near real-time with confirmed receipt and acknowledgement. It provides a framework for seamless communication across the entire medical device spectrum for an automated, immediate, and secure delivery of patient electronic device information, device recalls, standards of care reminders and more.

For more information: https://careier.com/

About iRxReminder, LLC:

iRxReminder is a Cleveland, Ohio-based medication monitoring platform service provider focused on moving mental health patients from crisis to control by monitoring medication taking to achieve and sustain independence. It's completely patient-centered and addresses accountable care and population-health-management goals, so patients can achieve high medication adherence. iRxReminder provides effortless monitoring of medication taking and triggers interventions by staff, as needed, to improve healthcare outcomes.

Additionally, the data from monitoring and intervention activities allows agencies to complete more reimbursable activities to help increase their revenue up to 70 percent.

iRxReminder works with Harvard University, The University of Michigan Cancer Center, George Mason University, Case Western Reserve University, Kent State University, University of Wisconsin School of Medicine and Summa Health System. The company plans to evolve with FDA clearance of the iLidRx, its Internet of Things pill dispenser that verifies medication dispensing as a 510(k) Class II medical device.

The iRxCapture app, available in the Apple App and Google Play stores.

For more information: https://www.irxreminder.com/

iRxReminder, a medication monitoring platform service, recently teamed up with CAREier, the revolutionary medical device communication company, to ensure its patients remain safe and independent. CAREier is revolutionizing medical device communications to finally include the patient.

Related link: https://careier.com/

World Renowned Patient Safety Champion Joins CAREier Advisory Board

POTOMAC, Md. /ScoopCloud/ -- CAREier, Inc., the revolutionary medical device communication company, is building an advisory board of patient safety and healthcare industry powerhouses. Its latest addition is world renowned, Peter J. Pronovost, M.D., Ph.D., F.C.C.M., a critical care physician and prolific researcher who has published more than 800 peer review publications; his scientific work has saved thousands of lives.

"We're absolutely thrilled that Dr. Pronovost has joined our advisory board," Ryan Bass, founder and CEO, CAREier says. "As a global thought leader who has influenced U.S. and global health policy, I'm confident he will help us to champion a new chapter in healthcare IT, patient safety and medical device communication."

When Bass founded CAREier, he sought to turn the world of medical device communication on its head. He didn't just want an incremental improvement to the processes used today, he wanted to change the system - and eventually the world's standards for patient level communication expectations. There's no other platform like it.

CAREier provides a framework for seamless communication across the entire medical device spectrum for an automated, immediate, and secure delivery of patient electronic device information, device recalls, standards of care reminders and more.

"We really work from the top down," Bass says. "Everyone from the FDA to the patient is part of our holistic network. And we're sure that our advisory board will help us to build a better medical device communication ecosystem. I'm truly humbled and honored to have Dr. Pronovost on board."

In 2005, Dr. Pronovost was involved in the launch of a leading solution to the medical device communication problem and since then, he says he hasn't seen any real innovation - that is - until now.

"Almost 20 years ago, I was involved in developing systems and processes related to the recalls experienced by health systems. Since then, innovation in this space has been slow and I was excited when CAREier approached me with their pioneering solution. CAREier is not an incremental improvement to today's workflows, but is a transformative approach to more efficiently and effectively manage recalls and improve safety."

About Peter J. Pronovost, M.D., Ph.D., F.C.C.M.:

Dr. Pronovost is the Chief Quality and Clinical Transformation Officer at University Hospitals. His entrepreneurial patient safety endeavors have earned him high-profile accolades - including being named one of the 100 most influential people in the world by "Time" magazine, receiving a coveted MacArthur Foundation "genius grant" in 2008.

In his current role, he fosters ideation and implementation for new protocols to eliminate defects in value to enhance quality of care; develop new frameworks for population health management for its more than 1 million patients; and manage the UH Accountable Care Organization (ACO) Network - one of the nation's largest. His primary focus is to keep people "Healthy at Home." In just 12 months, one of his concepts fueled a reduction in annual costs per patient in the UH ACO by nine percent.

He's also served as the senior vice president for Patient Safety and Quality at Johns Hopkins Medicine as well as the founder and director of the Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality. While there, he worked to eliminate all harms in one health system following on his success in eliminating one harm in most health systems across the U.S.

For a complete bio: https://www.uhhospitals.org/about-uh/leadership/uh-system-leadership/peter-pronovost

About CAREier:

CAREier is revolutionizing medical device communications to finally include the patient. Its mission is to create a complete communication ecosystem between regulators, medical device manufacturers, healthcare providers, physicians and patients to transmit urgent messages in near real-time with confirmed receipt and acknowledgement.

For more information: https://careier.com/

CAREier, Inc., the revolutionary medical device communication company, is building an advisory board of patient safety and healthcare industry powerhouses. Its latest addition is world renowned, Peter J. Pronovost, M.D., Ph.D., F.C.C.M., a critical care physician and prolific researcher who has published more than 800 peer review publications; his scientific work has saved thousands of lives.

Related link: https://careier.com/

Innovative, Removable Mesh Sling Now Available for Exclusive Manufacture

LOS ANGELES, Calif. /ScoopCloud/ -- California firm, ProNova Partners, has been chosen to handle the sale of the patent and rights to an easily removable mesh sling based on the natural encapsulation around monofilament wires or its interconnected narrow and flat strips. This encapsulation allows its easy removability.

15-year-old Mergers and Acquisitions firm, Los Angeles based ProNova Partners, has announced their commission to facilitate the sale of a new, patented technology for the repair of urine and fecal incontinence. This breakthrough has the potential to take over almost the entire incontinence repair market valued at billions of dollars.

"We are proud that our work worldwide has now enabled us now to assist in bringing a life-transforming technology to the market for manufacture," stated Rick Carlson CEO and founder of ProNova Partners.

In the almost two decades of its existence, ProNova Partners has overseen the sale of more than 400 opportunities in divergent areas. "This broad experience in multiple areas of the marketplace has been critical to our work in the medical and tech arenas," Carlson continued.

The patented "sling" technology available for rights purchase comes in 3 versions, all covered by patents: a weaved version, a detachable flat version, and an inflatable version for adjustment of the sub-urethral support.

The developer, an MD and a prolific inventor who owns more than 20 issued US and tens of International Patents says, "The weaved version of the sling we developed looks similar to the currently available synthetic slings and can be made from the same materials. However, there are some significant differences: differing from all the other available slings ours are not knitted, they are weaved making them more flexible and thinner."

"We are proud to be offering the full rights and ownership of this technological breakthrough into the marketplace for manufacture," concluded Carlson. "The offering includes all patents and will improve quality of life immediately for hundreds of thousands of patients, and once released those numbers will grow to millions."

For detailed information go to: https://pronovapartners.com/engagement/patented-easily-removable-sub-urethral-sling-medical-device-company-for-sale/

California firm, ProNova Partners, has been chosen to handle the sale of the patent and rights to an easily removable mesh sling based on the natural encapsulation around monofilament wires or its interconnected narrow and flat strips. This encapsulation allows its easy removability.

Related link: https://www.pronovapartners.com/

New, Patented Device for Quick, Painless, Non-Invasive Elimination of Hemorrhoids Now Available with All Rights for Manufacture

LOS ANGELES, Calif. /ScoopCloud/ -- ProNova Partners, a seventeen-year-old California based Mergers and Acquisitions firm, has been commissioned to assist in the sale of all rights to manufacture and sell a patented, painless, non-invasive, device to eliminate hemorrhoids. Use of the device requires no anesthesia, is conducted in under 2 minutes, and can be performed in any medical setting: a doctor's office, a surgery center, an endo suite, or a hospital.

This technology has yielded a painless, non-invasive, no anesthesia needed device to eliminate hemorrhoids in under 2 minutes. The procedure can be performed in any medical setting.

"Over half of adults suffer from this affliction at one time or another," stated Rick Carlson founder and CEO of ProNova Partners. "This Doctor developed device offers a fast, painless and permanent solution."

Carlson's firm has helped the expansion or sale of some 400 companies in a wide variety of market segments.

This latest commission for ProNova is designed to structure movement of the patent, sale, and manufacturing rights of a much-needed device to an outside company. The goal is quickly move the technology out and into the medical marketplace. The product, developed and currently sold on a limited basis in the US, was originated by a gastroenterologist. It is currently sold directly to physicians of different specialties, including gastroenterologists, colorectal surgeons, GYNs, urologists and primary care physicians. The biggest targeted audience is gastroenterologists.

"Huge numbers of patients now no longer need to use ineffective creams or receive painful, invasive surgery," concluded Carlson. "This device offers a permanent, painless solution."

For detailed information go to: https://pronovapartners.com/engagement/patented-medical-device-company-for-hemorrhoid-removal-for-sale/

ProNova Partners, a seventeen-year-old California based Mergers and Acquisitions firm, has been commissioned to assist in the sale of all rights to manufacture and sell a patented, painless, non-invasive, device to eliminate hemorrhoids. Use of the device requires no anesthesia, is conducted in under 2 minutes, and can be performed in any medical setting: a doctor's office, a surgery center, an endo suite, or a hospital.

Related link: https://www.pronovapartners.com/

AI Radiology and Emerging Medical Technology Venture Capital Investment Group Now Open to Outside Participation

LOS ANGELES, Calif. /ScoopCloud/ -- Seventeen-year-old ProNova Partners has been contracted to facilitate the expansion of an Artificial Intelligence Radiology Imaging and emerging Medical Technology Venture Capital Investment Group.

"This venture capital investment partnership was founded in 2018," announced Rick Carlson, CEO of ProNova Partners. "On behalf of their members, they find and invest in game changing, cutting edge, emerging companies specializing in Artificial Intelligence Radiology Imaging and other Medical Technologies."

"The group is owned and operated by three managing partners with broad ranging domain expertise," continued Carlson. "We are very pleased to work with such a qualified group. They are finding and investing at the early stages in firms at the razor's edge of Artificial Intelligence in medical technology." Carlson's company has assisted the expansion or sale of some 400 companies in a wide variety of market segments.

"The investment group has already seen high quality, sector specific deal flow, and boasts of a robust current portfolio of investments in leading edge technologies," concluded Carlson.

"The investment firm's distinguished Managing Partners' combined credentials span venture capital investment expertise. This includes domain expertise in radiology covering a broad range of aspects of radiology and MRI imaging, entrepreneurship, artificial intelligence, and other emerging medical technologies. Their combined knowledge and experience establish them as ideally suited to spearhead the formation of a selected group of physician and non-physician investors plus providing groundbreaking leadership in early stage company investments in the AI/Imaging/Radiology sector."

For detailed information go to: https://pronovapartners.com/engagement/ai-radiology-and-emerging-technology-firm-for-sale/

Seventeen-year-old ProNova Partners has been contracted to facilitate the expansion of an Artificial Intelligence Radiology Imaging and emerging Medical Technology Venture Capital Investment Group.

Related link: https://www.pronovapartners.com/

ViewTech Borescopes Exhibiting Again at INTERPHEX 2022

TRAVERSE CITY, Mich. /ScoopCloud/ -- Industry pharmaceutical and biotech professionals from across the globe will convene at INTERPHEX 2022 at the Javits Center in New York City beginning May 24 through 26. The 3-day technical conference also features an exhibit hall with more than 400 exhibitors. ViewTech Borescopes and their lineup of articulating video borescopes will be on display at booth #1939.

After first exhibiting at INTERPHEX 2021, ViewTech connected with engineers and manufacturers seeking inspection and quality control remote visual inspection (RVI) equipment. The VJ-3 Ultraviolet (UV) video borescope is widely utilized during cleaning validation, riboflavin testing, and as part of a sanitary process solution. In addition to the VJ-3 UV video borescope, the VJ-3 Dual Camera and VJ-3 3.9mm will be featured at ViewTech Borescopes booth at INERPHEX 2022.

Zack Wessels, Senior Sales Consultant for ViewTech, will be available during exhibit hall hours to discuss any future maintenance, inspection, or quality control requirements where a VJ-3 video borescope could reduce downtime. With ViewTech Borescopes no-cost, no-obligation demo program, pharmaceutical and biotech companies can trial a VJ-3 video borescope at their own facility.

Learn more about INTERPHEX: https://www.viewtech.com/tradeshows/interphex-2022

VJ-3 Video Borescope:

The VJ-3 mechanical articulating video borescope is a nondestructive visual testing instrument used for the remote visual inspection of machinery, equipment, and components. The VJ-3 facilitates the visual recording and photo documentation of an inspection and components in areas that are otherwise inaccessible or require great effort and expense to access directly. The VJ-3 consists of two modules integrated into one system: an insertion tube with distally mounted camera/LEDs, and the base unit with control panel, LCD monitor, power source and all necessary circuitry.

About ViewTech Borescopes:

ViewTech Borescopes, founded as RF System Lab in 2008, is North America's #1 seller of video borescopes. Their first product, the VJ borescope, set a new standard for portability, ergonomics and ease-of-use, with its industry-first mechanical, joystick-controlled articulation.

Learn more: https://www.viewtech.com

Industry pharmaceutical and biotech professionals from across the globe will convene at INTERPHEX 2022 at the Javits Center in New York City beginning May 24 through 26. The 3-day technical conference also features an exhibit hall with more than 400 exhibitors. ViewTech Borescopes and their lineup of articulating video borescopes will be on display at booth #1939.

Related link: https://www.ViewTech.com

Life Saving Device for Major Heart Surgery Procedure Now Available for Exclusive Manufacture

LOS ANGELES, Calif. /ScoopCloud/ -- ProNova Partners, a Los Angeles based, 25-year-old Mergers and Acquisitions (M&A) firm has announced their commission to facilitate the sale of a new, patented device to lower mortality and other risks in specific, major heart surgery procedures.

The device lowers mortality, stroke risk and other risk factors in Transcatheter Aortic Valve Implantation (TAVI) or transcatheter aortic valve replacement (TAVR) procedures.

"We are very pleased that our past work, both nationally and internationally, has enabled us now to assist in bringing a life-saving device to the market for manufacture," announced Rick Carlson CEO and founder of ProNova Partners.

ProNova Partners has facilitated the sale of over 400 various opportunities in divergent areas. "This broad range of experience and exposure in multiple areas of the marketplace has been very helpful to our consultation work in the medical and tech arenas," Carlson stated.

The patented device available for rights purchase can simply be added to existent equipment to immediately improve patient outcomes. It was developed by a renowned M.D. and professor, a prolific inventor who owns more than 20 issued U.S. and tens of International Patents and a similar number of pending patents.

According to the developer "The vision of our Project (was) to significantly improve the safety of TAVI/TAVR. Integrating or adding-on an active double-filtering, emboli capturing, collecting and removal component to the TAVI/TAVR procedure is a breakthrough. With our approach, we are bringing a better solution than the currently used deflective anti-embolic devices for preventing cerebral embolic complications."

"We are proud and pleased to be a part of offering the full rights and ownership into the marketplace for manufacture," concluded Carlson. "It will both save lives and improve quality of life immediately for hundreds of thousands of patients and once released those numbers will grow to millions."

For detailed information go to: https://pronovapartners.com/engagement/medical-device-company-for-major-heart-surgery-for-sale/

ProNova Partners, a Los Angeles based, 25-year-old Mergers and Acquisitions (M&A) firm has announced their commission to facilitate the sale of a new, patented device to lower mortality and other risks in specific, major heart surgery procedures.

Related link: https://www.pronovapartners.com/

Zeteo Biomedical Introduces OrionMRQ™ Nasal Delivery Device for Vaccines

PFLUGERVILLE, Texas /ScoopCloud/ -- Zeteo Biomedical LLC announced today the availability of the ZEOx1 OrionMRQ™ nasal drug and vaccine delivery device. Zeteo's latest innovative delivery device provides pharmaceutical and biotech companies developing drugs, peptides, proteins, monoclonal antibodies and vaccines with precise, metered unit dose systemic delivery via the nasal route.

Nasal administration provides needle free, rapid systemic uptake into the body via the nose. Nasal delivery of vaccines can invoke a fast local immune response in the respiratory track, which is frequently the primary route of infection for contagious pathogens such as pandemic flu or coronavirus. The ZEOx1 OrionMRQ™ device is intuitive to use, enabling either patient self-administration or administration by caregivers with configurations available for both adults and children.

The OrionMRQ reloadable nasal delivery device has the capability to store up to four unit doses in the on-board storage compartment. The device is compact making it easy to carry in a pocket or purse. Zeteo intranasal delivery devices incorporate novel packaging technology utilizing a Form Fill Seal (FFS) flexible foil, packaging the drug or vaccine in a unit dose blister reducing the cost and eliminating the supply chain constraints of glass vials.

ZEOx1™ blister packaging provides exceptional barrier properties to protect the drug or vaccine during storage and transport and can be stored at room temperature, refrigerated or frozen storage conditions. The ZEOx1™ packaging technology is commercially scalable to produce millions of doses per day; a critically important requirement for rapid, cost effective deployment of vaccines and medical countermeasures to global populations.

About Zeteo Biomedical LLC:

Zeteo Biomedical™ is a biomedical device technology company based in Austin, Texas. Zeteo provides patient-centric delivery device technology, drug/device combination product development services and fill/finish packaging technology for pharmaceuticals, biopharmaceuticals, biologics and botanicals for intranasal, nose-to-brain, ophthalmic, sublingual, and animal care product applications.

For more information, please visit the Zeteo website at: https://www.zeteobiomed.com/

Zeteo Biomedical LLC announced today the availability of the ZEOx1 OrionMRQ™ nasal drug and vaccine delivery device. Zeteo's latest innovative delivery device provides pharmaceutical and biotech companies developing drugs, peptides, proteins, monoclonal antibodies and vaccines with precise, metered unit dose systemic delivery via the nasal route.

Related link: https://www.zeteobiomed.com/

Key Entrepreneurs to Present at 2022 Bioelectronic Medicine Forum

NEW YORK, N.Y. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that founders and CEOs of several promising bioelectronic medicine startups will present at the Fifth Annual Bioelectric Medicine Forum on April 5, 2022. The event will take place in New York City, although participation via Zoom videoconference will be accommodated.

Entrepreneur presenters at the conference include Attila Borbath, CEO of Synergia Medical, a European firm developing an optical vagus nerve stimulation system, Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, Jennifer Ernst, CEO of Tivic Health, Manfred Franke, CEO of Neuronoff Inc., and Anuj Bhardwaj, CEO of SecondWave Systems Inc.

Peter Staats, a bioelectronic medicine pioneer and co-founder and chief medical officer of electroCore Medical, will keynote the conference. Dr. Staats is internationally recognized for his work in developing and implementing minimally invasive procedures for a number of disorders, including COVID, and his patents have led to the use of novel pharmacologic agents. He is a past President of the North American Neuromodulation Society, American Society of Interventional Pain Physicians, New Jersey Society of Interventional Pain Physicians, and the Southern Pain Society.

Other speakers at the 2022 event include Marom Biksom, professor of biomedical engineering at City College of New York, Imran Eba, partner at Action Potential Venture Capital, Chihiro Hosoya, head of venture management and business development at Astellas Pharma, Eric Hudak, program director at the National Institutes of Health, and Hannah Claridge from TTP plc in the U.K.

Other sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties.

MST is the Platinum Sponsor of this year's event, while Valtronic is the Silver Sponsor.

Key topics will include promising new indications, alliances with bio/pharm firms, regulatory and reimbursement issues, and pricing/commercialization issues.

"Bioelectronic medicine is one of the most promising new segments of the healthcare industry," said James Cavuoto, editor and publisher at Neurotech Reports. "This fifth-annual conference will be a key meeting place for entrepreneurs and executives helping to found this industry."

For more information on the 2022 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

RELATED LINKS:
https://www.neurotechreports.com/

Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that founders and CEOs of several promising bioelectronic medicine startups will present at the Fifth Annual Bioelectric Medicine Forum on April 5, 2022. The event will take place in New York City, although participation via Zoom videoconference will be accommodated.

Related link: http://www.neurotechreports.com/

Mopec Introduces Guardian Quick-Deploy Coolers under Guardian Systems Line

MADISON HEIGHTS, Mich. /ScoopCloud/ -- Mopec, the nationwide leader in pathology, anatomy, mortuary and necropsy equipment and supplies, is proud to announce the latest innovation and addition to its Guardian Systems product line. The Mopec Guardian Quick-Deploy Cooler is adaptable, portable, and is a rapidly deployable system for the long term storage of human remains.

Mopec has integrated its new patented rack technology along with patent-pending insulation technology to create an expandable remains storage platform that will instantly increase morgue surge capacity. This compact, rapidly deployable system can be easily transported and assembled in under 30 minutes with no tools required.

While the current system holds 12 bodies, the optional expansion module allows the system to quickly expand from holding 12 decedents to 24. Mopec will also be introducing a smaller, 110V 4-body version in the next few months that will allow the user to easily plug it into any regular outlet.

"The Guardian Quick-Deploy Cooler addresses the needs for many of our customers dealing with surge capacity," says Kirk Gossett, Vice President of Sales for Mopec. "Plenty of organizations are still struggling to find immediate solutions when decedent capacity overwhelms their current availability. Mopec hopes that this portable, expandable, and quick-assembly system can help resolve these issues."

Guardian Quick-Deploy Coolers are included under the Mopec Guardian Systems line and are the ultimate solution when dealing with surge capacity morgue overflow. While the first production run of coolers has already sold out, Mopec is currently accepting pre-orders for the second run of products.

For more information, or to obtain a quotation, please visit https://www.mopec.com/, or call (800) 362-8491.

About Mopec:

Mopec, based in Madison Heights, Michigan, is a manufacturer and distributor of high-quality pathology, anatomy, mortuary, and necropsy equipment and products. Founded in 1992, Mopec differentiates itself through its extensive engineering process, superior design, and market-leading quality. Mopec is Better By Design and specializes in solutions for hospitals, universities, morgues, and a variety of other markets. Mopec is committed to the production innovative products and providing high quality customer service. For more information, visit https://www.mopec.com/.

Mopec, the nationwide leader in pathology, anatomy, mortuary and necropsy equipment and supplies, is proud to announce the latest innovation and addition to its Guardian Systems product line. The Mopec Guardian Quick-Deploy Cooler is adaptable, portable, and is a rapidly deployable system for the long term storage of human remains.

Related link: https://www.mopec.com/

Olea Kiosks, Inc. Delivers Height Adjustable Austin Kiosk for Healthcare

LOS ANGELES, Calif. /ScoopCloud/ -- Olea Kiosks®, Inc., a visionary provider of innovative self-service kiosk solutions, today announced the addition of its height adjustable base for the Austin series kiosk. This new addition is available for ordering now.

Aimed at healthcare, this unit delivers full ADA (Americans with Disabilities Act) height compliance as all of the user touch points can be positioned at a height under 48 inches. At the push of a button, the base raises and lowers a total of 11.9 inches to provide users of all heights and abilities an improved user-experience.

The Austin is the most popular kiosk Olea sells with over 2500 sold since its inception in 2018 The Austin Height Adjustable (HA) combines the height adjustable base with the desktop unit to deliver a slick, compact and versatile self-service solution perfect for healthcare check-in. The Austin is also very popular with hospitality and frequently used in quick-serve restaurants (QSR) and ticketing where this functionality is a welcome addition.

"The Austin HA comes at a time when healthcare and businesses in general are constrained by the lack of human resources available," said CEO Frank Olea. "Our engineering team worked extra hard to turn this unit around in a record amount of time," added Olea.

In addition, an optional UV sanitizing system utilizing two powerful Mercury Vapor bulbs are now available with all of the Austin model kiosks. The cleaning cycle allows for sanitization of the touchscreen as well as the payment device. "We're excited to bring this feature to market as we felt there was a need to keep not only the screens clean but the buttons on the pin-pads as well," added Olea.

The Austin series kiosk is now available in 4 options: the HA, the Freestanding (FS), the Desktop (DT), and the Wall-mount (WM). The Austin model supports a host of external devices.

Link to video: https://vimeo.com/591165564/21b4f37bdd

About Olea Kiosks®, Inc.

Olea Kiosks Inc., is a self-service kiosk solution provider for the attractions and entertainment, healthcare and hospitality industries. Its technologically advanced, in-house manufacturing, design, and innovation have made it an industry leader. Headquartered in Los Angeles, California, customers include Cedars-Sinai, Kaiser Permanente, Tenet, The Habit Burger Grill, The Empire State Building, Universal Studios, Scientific Games, and Subway.

For more information, visit https://www.olea.com/.

MULTIMEDIA:

*PHOTO link for media: https://www.Send2Press.com/300dpi/21-0824s2p-olea-austin-300dpi.jpg

*Caption: The Austin Height Adjustable Kiosk.

Olea Kiosks®, Inc., a visionary provider of innovative self-service kiosk solutions, today announced the addition of its height adjustable base for the Austin series kiosk. This new addition is available for ordering now.

Related link: https://www.olea.com/

Lift & Care Systems Continues COVID-19 Precautions to Protect Customers

LAKEVILLE, Mass. /ScoopCloud/ -- Now that the worst of the global COVID-19 pandemic seems to be behind us, Lift & Care Systems continues its commitment to the safety of customers, employees, and suppliers. However, with the arrival of the Delta variant and the emergence of other strains of the virus, the Lift & Care team continues to take precautions to ensure the health of everyone they come in contact with.

The Lift & Care Systems staff went to great lengths to provide top-notch service to our customers during this difficult time. Some of the steps that they have taken to provide reliable and safe service include:

* Educating the staff about how to follow the state-mandated protocols properly

* Cleaning and disinfecting all equipment, vans, and offices often

* Minimizing the number of touches and home visits needed to provide customer service for our products

* Getting our staff vaccinated as soon as the immunizations were available

* Working remotely and using Zoom to facilitate meetings, training, and calls on customers whenever possible

* Masking and following the appropriate social distancing guidelines

"We are proud of how our team pulled together during this difficult time and continued to serve our customers," says Dave Austin, President of Lift & Care Systems. "Our team understands the impact of this virus on our customers, many of whom are vulnerable and cannot afford getting infected with COVID on top of their current medical issues."

Lift & Care's workers have been vaccinated against COVID-19 and plan on receiving boosters as they become available. Our staff will also continue to monitor state and CDC guidelines to follow the up-to-date procedures for keeping our customers safe. This includes wearing masks (if requested) and practicing social distancing to ensure the health and safety of everyone they come in contact with.

"We kept working through the pandemic just as we have over the last 28 years," continued Austin. "Servicing new and existing customers throughout Massachusetts, Connecticut, and Rhode Island while providing that best service possible under difficult circumstances.

About Lift & Care Systems, Inc.

Lift & Care Systems, Inc is dedicated to bringing the highest quality of life to users and their caregivers by providing customized solutions that enhance the users' mobility. To achieve this goal, Lift & Care Systems offers a myriad of products, including Body Supports, Slings, Mobile Lifters, Ceiling Systems, Wall-to-Wall Lift Systems, Wheelchair-to-Water Pool Lifts, Frictionless Slides, stairlifts, aluminum ramps, accessible shower stalls, lifts for cars/vans/SUV's with the Multi-Lift and Glide 'N Go.

Their products are used in private residential homes, semi-professional homes, such as group homes and day programs, and professional institutions, including nursing homes, hospitals, and schools. Lift & Care Systems is the exclusive distributor of the SureHands patient lifts featuring the patented Body Support systems in Massachusetts, Rhode Island, and Connecticut. In addition, Lift & Care Systems product line also includes National Ramp Systems and a broad array of stairlifts for in-home use.

Founded in 1993, Lift & Care Systems, Inc. is located at 7 Precinct Street in Lakeville, MA 02347. For additional information or to arrange for a free personal consultation, please call 508-465-5254.

Now that the worst of the global COVID-19 pandemic seems to be behind us, Lift & Care Systems continues its commitment to the safety of customers, employees, and suppliers. However, with the arrival of the Delta variant and the emergence of other strains of the virus, the Lift & Care team continues to take precautions to ensure the health of everyone they come in contact with.

Related link: http://www.liftandcaresystems.com/

Zootility Introduces Hover Shield For Travel, Designed To Fit Disposable Masks

PORTLAND, Maine /ScoopCloud/ -- Zootility, a design-driven US manufacturing company, announces a breakthrough innovation - the first travel eye shield, known as Hover Shield, that attaches to any disposable mask. Unlike any of its conventional bulky design predecessors, the nearly invisible Hover Shield provides an attractive solution for traveling, seasonal allergies, yard work, large public gatherings, institutional settings, and working in dusty environments.

Zootility's patent-pending loop hooking design allows the Hover Shield to be easily attached to any disposable mask with ear loops without applying any pressure to the face. The low-cost disposable shield was developed in part with support from the Maine Technology Institute (MTI).

The lightweight and transparent construction of the Hover Shield makes it barely noticeable. The Hover Shield seamlessly extends above any mask to cover the rest of the face. Other key features include universal attachment, adjustable angle, no straps and no pressure points design. Hover Shield also solves one of the biggest complaints wearers have with traditional face shields - fogging from their own warm exhalations. Hover Shield is available with an anti-fogging coating option.

"No one wants to wear a bulky eye shield when traveling. Hover Shield was created by travelers for travelers with comfort in mind and is perfect for air travel. Hover Shield deflects droplets from traveling directly into the eyes without obscuring the vision or adding the bulk that comes with conventional face shields. It basically just hovers there!" says Nate Barr, Founder of Zootility.

The product launch comes as more people worldwide are beginning to travel for the first time in a year amidst COVID numbers slowly increasing due to the highly virulent Delta variant. The CDC has long recommended eye protection in addition to a face mask whenever masking is required. Until now, there has not been a cost-effective solution for eye protection. The Hover Shield makes that recommendation easier to follow.

Visit Zootility's Kickstarter page to order your Hover Shield, meet the creators, and learn more about the product that is changing the way we travel: https://www.kickstarter.com/projects/zootility-health/hover-shield.

Zootility designs, launches, and manufactures exciting functional everyday products that solve interesting problems using clever solutions, quality materials, and futuristic technology. For more information on Zootility, please visit http://www.zootility.com/.

MULTIMEDIA:

*PHOTO LINK for media: https://www.Send2Press.com/300dpi/21-0715s2p-zootility-300dpi.jpg

Caption: Zootility's travel eye shield, known as Hover Shield, attaches to any disposable mask.

Zootility, a design-driven US manufacturing company, announces a breakthrough innovation - the first travel eye shield, known as Hover Shield, that attaches to any disposable mask. Unlike any of its conventional bulky design predecessors, the nearly invisible Hover Shield provides an attractive solution for traveling, seasonal allergies, yard work, large public gatherings, institutional settings, and working in dusty environments.

Related link: https://zootility.com/

Phoenix LTC Selects SecuGen’s U20-A Fingerprint Sensor for Safer Dispensing of Medication

SANTA CLARA, Calif. /ScoopCloud/ -- SecuGen is pleased to announce that Phoenix LTC has selected SecuGen's U20-A fingerprint sensor to integrate secure biometric technology into StatSafe, an automated medication management system used in skilled nursing and long-term facilities.

Phoenix LTC designs the StatSafe line of medication cart solutions that organize, store, and secure medication for use in diverse markets, from skilled nursing to independent living. They needed a way to authenticate care providers who are authorized to access the locked carts. Phoenix LTC found the biometric security offered by SecuGen's fingerprint technology delivers highly accurate recognition that is difficult to falsify and impossible to forget. The addition of biometrics provides a means of quickly and reliably verifying user identity so that healthcare providers can administer medication to patients more efficiently and safely.

"We needed to add biometric security into our existing product line, and SecuGen fit the need perfectly," stated John Bergmann, owner of Phoenix LTC. "We selected the U20-A sensor primarily for its quality, accuracy and reasonable price. Working with SecuGen was a pleasure. We appreciate their customer focus and attention on providing support and software development kits that were critical in the integration of the fingerprint sensor into our product."

The U20-A is a flagship of SecuGen's USB fingerprint sensors specifically designed for OEMs and boasts desirable features such as high image quality, utility, ruggedness, and price performance. SecuGen offers a broad line of OEM sensors including stand-alone systems and fingerprint sensors suitable for almost any application. SecuGen OEM sensors have been integrated into a wide variety of products such as ATMs, gun safes, kiosks, manufacturing equipment, physical access control terminals, and time & attendance machines marketed throughout the world.

Jeff Brown, VP of Sales for SecuGen added, "We are thrilled to see our fingerprint technology working for Phoenix LTC. They have put a lot of thought into the design and functionality of their products and saw a clear need for the added security of biometrics. We are very pleased that they have chosen our U20-A sensor."

"It's exciting to meet new customers with creative ideas for implementing our biometric technology into their applications," stated Won Lee, President and CEO of SecuGen. "Biometrics is a powerful tool, and we are glad to help them harness this power with our OEM sensor products and development resources."

About Phoenix LTC

Phoenix LTC is committed to providing innovative solutions that improve the overall patient medication experience. Our medication cart solutions serve many different markets - from skilled nursing to independent living. Nearly 10 years ago StatSafe was introduced to the market as the original, cost-effective automated medication management system. The newest generation uses the latest hardware technology and smart software to create a safer and more efficient stat dose process with uncompromising security, traceability and simplicity. More information about StatSafe can be found at: https://phoenixltc.com/statsafe-automated-medication-management/

About SecuGen

SecuGen Corporation ( https://secugen.com ) is the world's leading provider of advanced, optical fingerprint recognition technology, products, tools and platforms for physical and information security. SecuGen designs and develops FBI-certified fingerprint readers and OEM components, developer kits and software, including NIST/MINEX-compliant algorithms.

For over 20 years, SecuGen has been a driving force committed to delivering high quality, innovative, rugged, and price-performing products for a wide variety of applications such as insurance and banking, medical and health care, point of sale, logical and physical access control, mobile devices, AFIS and law enforcement, national ID, voter registration, SIM card authentication, fleet management, and many more.

SecuGen products are used by world-leading financial, medical, government, educational and corporate institutions and are sold through an extensive partner network of reseller partners including original equipment manufacturers, independent software vendors and system integrators in North America, Latin America, Africa, Middle East, Europe, and Asia.

SecuGen is a registered trademark of SecuGen Corp. in the United States and other countries.

SecuGen is pleased to announce that Phoenix LTC has selected SecuGen's U20-A fingerprint sensor to integrate secure biometric technology into StatSafe, an automated medication management system used in skilled nursing and long-term facilities.

Related link: https://secugen.com/

Lift & Care Systems Now Accepts Medicare and Medicaid for Patient Lifts in Massachusetts

LAKEVILLE, Mass. /ScoopCloud/ -- Lift & Care Systems is happy to announce that they earned accreditation to accept Medicare and Massachusetts Medicaid for patient lifts. The certification, granted by the Healthcare Quality Association on Accreditation (HQAA), allows Lift & Care Systems to sell and service SureHands ceiling lifts for Medicaid and Medicare customers. There are some limitations to the patient lifts eligible for the program based on the individual customer's insurance coverage.

To get pricing for a ceiling lift system using Medicare or Medicaid, bring your Medicare, Massachusetts Medicaid, and any other proof of insurance, so the Lift & Care Services team to enter into the system to see what you qualify for. Participants in this program must be Massachusetts residents.

"Times are hard right now for a lot of people," said Dave Austin, President of Lift & Care Systems. "We are happy to serve these segments of the community who need SureHands ceiling lifts but can't afford them without the help of Medicaid or Massachusetts Medicaid."

Lift & Care Systems has been an authorized seller of SureHands patient lift systems for over 27 years and is one of the country's top suppliers of SureHands patient lift systems. For additional information about the program or to arrange for a free personal consultation, please call 508-465-5254.

About Lift & Care Systems, Inc.

Lift & Care Systems, Inc is dedicated to bringing the highest quality of life to users and their caregivers by providing customized solutions that enhance the users' mobility. To achieve this goal, Lift & Care Systems offers a myriad of products, including Body Supports, Slings, Mobile Lifters, Ceiling Systems, Wall-to-Wall Lift Systems, Wheelchair-to-Water Pool Lifts, Frictionless Slides, stairlifts, aluminum ramps, and accessible shower stalls.

Their products are used in private residential homes, semi-professional homes, group homes and day programs, and professional institutions, including nursing homes, hospitals, and schools. Lift & Care Systems is the exclusive distributor of the SureHands patient lifts featuring the patented Body Support systems in Massachusetts, Rhode Island, and Connecticut. In addition, Lift & Care Systems product line also includes National Ramp Systems and a broad array of stairlifts for in-home use.

Founded in 1993, Lift & Care Systems, Inc. is located at 7 Precinct Street in Lakeville, MA 02347. For additional information or to arrange for a free personal consultation, please call 508-465-5254.

INFO http://www.liftandcaresystems.com/

Lift & Care Systems is happy to announce that they earned accreditation to accept Medicare and Massachusetts Medicaid for patient lifts. The certification, granted by the Healthcare Quality Association on Accreditation (HQAA), allows Lift & Care Systems to sell and service SureHands ceiling lifts for Medicaid and Medicare customers.

Related link: http://www.liftandcaresystems.com/

Zeteo Biomedical Receives US Patent for Innovative Sublingual Delivery Device for Vaccines and Pharmaceuticals

AUSTIN, Texas /ScoopCloud/ -- Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its "Oral Delivery Device and Methods" (US Patent 10238577). This latest patent expands the capabilities of Zeteo's ZEOx1™ Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route.

Sublingual delivery has emerged as a viable route of administration for vaccines and medications for pain, cardiovascular, allergy, seizure, sedation and emesis. The sublingual route avoids first pass metabolism and provides rapid systemic uptake into the body providing advantages over traditional oral medications.

Zeteo's latest innovations expand its ZEOx1 Hydra™ sublingual delivery device family that include configurations for mono-dose disposable and mono-dose reloadable dispensers for vaccines, drugs, biopharmaceuticals, biologics and botanical liquid formulations. "We see expanding demand for metered dose sublingual delivery devices that are easy to use, convenient to carry, deliver a precise dose and can be self-administered," said Timothy Sullivan, President of Zeteo Biomedical.

Zeteo's delivery device technology and product integration services enable pharmaceutical and biotech manufacturers to develop drug/device combination products that can extend or establish market exclusivity and competitive differentiation for new or existing drugs and biologics. The shift to developing value added, patient-centric products benefit the consumer through improved compliance and health outcomes while building brand value for the pharmaceutical or biotech manufacturer. Zeteo's delivery platforms and products are designed to meet the diverse demands of consumers and pharma manufacturers in globally competitive markets.

About Zeteo Biomedical LLC

Zeteo Biomedical™ is a biomedical device technology company based in Austin, Texas. Zeteo provides patient-centric delivery device technology and unit dose fill/finish packaging for pharmaceuticals, biopharmaceuticals, biologics and botanicals for intranasal, nose-to-brain, ophthalmic, sublingual, and animal care product applications.

For more information, please visit the Zeteo website at: https://www.zeteobiomed.com/

Media Contact
Cathy Diehl
Zeteo Biomedical LLC
+(1) 512-614-0144
zeteo@zeteobiomed.com

*LOGO link for media: https://www.send2press.com/300dpi/20-1117s2p-zeteo-biomedical-300dpi.jpg

Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its "Oral Delivery Device and Methods" (US Patent 10238577). This latest patent expands the capabilities of Zeteo's ZEO Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route.

Related link: https://www.zeteobiomed.com/

JNL Technologies Launches Quantum SA Standalone Wander Management Control Unit

IXONIA, Wis. /ScoopCloud/ -- JNL Technologies, maker of Quantum nurse call, wander management, and access control systems, is now shipping Quantum SA, a standalone wander management system. Using the same proven Bluetooth technology as JNL's Quantum DCS product line, the Quantum SA does not require cable installation or the purchase of a Quantum server and is perfect for smaller areas that do not require centralized management.

"We are proud to release a version of our technology in a door monitor that doesn't require wire runs or a server to control it. The Quantum DCS has been installed in facilities across the country and works well in areas that other wander management systems fail due to old technology and interference issues," says JNL President, Jim Gleason. "We felt it was time to develop a cost effective, single door wander management control unit that can replace unreliable older systems."

To simplify installation, the Quantum SA controller provides industry standard input and output options, and in many cases, is a drop-in replacement. The controller and wander management transmitters are managed with a provided Android tablet. With the tablet, users are able to quickly adjust door settings, test transmitter batteries, and turn off unused transmitters.

According to Gleason, "We have always wanted to provide our wander management system to the entire market, and this allows us to do just that. To protect your investment, Quantum SA can be field upgraded when you are ready to transition to the full Quantum system."

The Quantum system is comprehensive and scalable and is designed to meet both budget and community size requirements. Due to this flexibility, Quantum has seen rapid adoption by facilities across the country. In an effort to meet this demand, JNL is actively recruiting new dealers.

More information: https://jnltech.net/quantum-sa-wander-management/

About JNL Technologies:

JNL is a leading provider of nurse call and resident monitoring technology in the senior housing market. JNL has over 30 years of hands-on experience in health care, nurse call, remote monitoring, and wander management technology. With a network of vetted and trained partners, JNL offers fully featured senior safety technology to long-term care communities.

For more information, visit https://jnltech.net/, or contact info@jnltech.net

*PHOTO link for media: https://www.Send2Press.com/300dpi/21-0209s2p-quantum-sa-300dpi.jpg
*Caption: JNL Technologies Quantum SA, a standalone wander management system.

JNL Technologies, maker of Quantum nurse call, wander management, and access control systems, is now shipping Quantum SA, a standalone wander management system. Using the same proven Bluetooth technology as JNL's Quantum DCS product line, the Quantum SA does not require cable installation or the purchase of a Quantum server and is perfect for smaller areas that do not require centralized management.

Related link: https://jnltech.net/

Mopec Introduces Disinfection and Air Purification Systems for Lab Safety

MADISON HEIGHTS, Mich. /ScoopCloud/ -- Mopec, the nationwide leader in pathology, anatomy, mortuary and necropsy equipment and supplies, announced two new products under their Guardian Systems line that are specifically designed to help improve disinfection processes and improve laboratory safety.

The BF1000 Series UV-C Disinfection Hood utilizes a UV-C light in 254nm wavelength that acts as a germicidal on the surface of objects in just minutes. The large opening lid and corner cover plates allow for small laboratory items to be places inside of the hood for disinfection prior to being brought into the laboratory environment or for general sample preparation.

The Disinfection Hood includes a dual mode power switch that allows for white LED lighting during normal use and UV-C lighting for disinfection. Available in single or dual UV-C lamp options, the timer dial is used to adjust minutes of exposure required to kill viruses and bacteria in only 10 minutes, and spores and fungi in only 15 minutes.

The BF840H PurePath HEPA System purifies the air in your laboratory multiple times per hour, allowing you to safely focus on your work with peace of mind. Constructed of all stainless steel, the BF840H is a modified version of Mopec's popular BF840 and now includes two Particulate filters as well as two HEPA filters.

The BF840H PurePath HEPA Air Purifier has the horsepower to capture 99.97% of common airborne particulates, viruses, bacteria, mold, and spores to help maintain a safe laboratory environment.

"Many of our customers have been looking for ways to improve the safety of their labs and help make their employees feel safe. With our decades of design and engineering experience, Mopec knew we could answer that call," said Jay Troger, CEO of Mopec.

For more information, or to obtain a quotation, please visit www.mopec.com, or call (800) 362-8491.

About Mopec

Mopec, based in Madison Heights, Michigan, is a manufacturer and distributor of high-quality pathology, anatomy, mortuary, and necropsy equipment and products. Founded in 1992, Mopec differentiates itself through its extensive engineering process, superior design, and market-leading quality. Mopec is Better By Design and specializes in solutions for hospitals, universities, morgues, and a variety of other markets. Mopec is committed to the production innovative products and providing high quality customer service. For more information, visit www.mopec.com.

*PHOTO link for media: https://www.Send2Press.com/300dpi/21-0126s2p-LabSafetyProducts-300dpi.jpg

*Capton: Mopec Lab Safety Products.

Mopec, the nationwide leader in pathology, anatomy, mortuary and necropsy equipment and supplies, announced two new products under their Guardian Systems line that are specifically designed to help improve disinfection processes and improve laboratory safety.

Related link: https://www.mopec.com/

Fluid Metering Inc. Announces the Launch of the FVD Series of Variable Dispense Pumps

SYOSSET, N.Y. /ScoopCloud/ -- Fluid Metering Inc. a microfluidic solutions provider is pleased to introduce the FVD series of variable dispense pumps (patent pending).

As microfluidics continue to emerge as powerful technology in the life sciences sector so is the desire to simplify fluidic architecture. The innovative, compact, low-profile design of Fluid Metering's Variable Dispense Pump address these challenging requirements with unparalleled accuracy and precision while doubling the lifecycle of current market technology.

Fluid Metering's Variable Dispense Pump high performance, technologically advanced design combines priming or washing, and a precise dispensing pump all in one complete package. The patented CeramPump® design utilizes a single, dimensionally stable and chemically inert ceramic "valveless" piston liner set for precise fluid control. This series of Variable Dispense Pumps provides the ability to have a higher flow rate for priming the line, and automatically adjusts to a small dispense volume ranging from liters to milliliters to microliters to accommodate the desired dispense or flows for any application.

"We are excited about the market changing capabilities that the launch of the Variable Dispense Pump will bring to the Life Sciences market. This innovative design has been through our most rigorous verification and validation process, with a test fleet of sixty units that have been through millions of flawless cycles. The FVD will help engineers simplify their fluidic architecture and improve instrument reliability," said Robert Morin, Vice President, Commercial Operations at Fluid Metering Inc.

About Fluid Metering Inc.

Fluid Metering Inc. pioneered the first patented valve-less rotating and reciprocating piston metering pump concept delivering pumping excellence and precise fluid control for Laboratory, Industrial, Process and OEM applications. Fluid Metering's Engineering Team incorporates over 60 years of OEM design experience to meet specific customer and application requirements with Accuracy, Precision & Reliability!

Learn more at: https://www.fluidmetering.com/

Follow Us

FACEBOOK: https://www.facebook.com/FluidMeteringInc/
TWITTER: https://twitter.com/fluidmetering
YOUTUBE: https://www.youtube.com/user/fmipump1959
LINKEDIN: https://www.linkedin.com/company/fluid-metering-inc-/?viewAsMember=true

Media Contact Information:
Name: Denise Sternbach
Phone: 516-922-6050 xt.113
Denise.Sternbach@fluidmetering.com

*PHOTO link for media: https://www.Send2Press.com/300dpi/21-0121s2p-fvd-series-300dpi.jpg

Fluid Metering Inc. a microfluidic solutions provider is pleased to introduce the FVD series of variable dispense pumps (patent pending). As microfluidics continue to emerge as powerful technology in the life sciences sector so is the desire to simplify fluidic architecture.

Related link: https://www.fluidmetering.com/

Mopec Now Offering Disposable Gowns and Shoe Covers under Guardian Systems Line of PPE

MADISON HEIGHTS, Mich. /ScoopCloud/ -- Mopec, the nationwide leader in pathology, anatomy, mortuary and necropsy equipment and supplies, introduced disposable shoe covers as well as two different types of disposable gowns under their Mopec Guardian Systems line of personal protective equipment (PPE).

The offerings include disposable poly gowns, level IV isolation gowns, and disposable shoe covers. Items will be sold individually and will range in price from $2 - $8, depending on the product. These new items will join Mopec's full line of FDA- and CE-compliant PPE, including full-length face shields, 3-ply and KN95 masks, no-contact infrared thermometers and hand sanitizer.

"With the ongoing COVID-19 pandemic, Mopec recognized a need for gowns that actually provide healthcare workers with an adequate level of protection," said Jay Troger, CEO of Mopec. "We understand that demands for PPE continue to increase for our customers, and we want to make sure we do everything we can to provide the products that they need."

Mopec's PPE offerings are just one aspect of the Mopec Guardian Systems line of COVID-19 Preparation and Response products. The line also includes Mobile Morgue Containers & Trailers for rental and purchase, Guardian Systems for Lab Safety products, the patented MERC Portable Cooling Systems, Body Bags, the Guardian Rack System, and the MaxAir CAPR System.

For more information, or to obtain a quotation, please visit https://www.mopec.com/, or call (800) 362-8491.

About Mopec

Mopec, based in Madison Heights, Michigan, is a manufacturer and distributor of high-quality pathology, anatomy, mortuary, and necropsy equipment and products. Founded in 1992, Mopec differentiates itself through its extensive engineering process, superior design, and market-leading quality. Mopec is Better By Design and specializes in solutions for hospitals, universities, morgues, and a variety of other markets. Mopec is committed to the production innovative products and providing high quality customer service. For more information, visit https://www.mopec.com/.

*PHOTO link for media: https://www.Send2Press.com/300dpi/21-0115s2p-mopec-covers-300dpi.jpg

*Caption: Disposable Gowns and Shoe Covers now available from Mopec

Mopec, the nationwide leader in pathology, anatomy, mortuary and necropsy equipment and supplies, introduced disposable shoe covers as well as two different types of disposable gowns under their Mopec Guardian Systems line of personal protective equipment (PPE).

Related link: https://www.mopec.com/

Fluid Metering Welcomes Dickson Ong as Business Development Manager for North America

SYOSSET, N.Y. /ScoopCloud/ -- Fluid Metering Inc. welcomes Dickson Ong as Business Development Manager - North America. Dickson will be the lead account manager of all North American key OEM accounts and will be responsible for growing business in North America by building relationships with FMI channel partners and strategic OEMs in the Life Science markets.

Dickson brings over ten years of application, new product development, application/sustaining engineering, and sales experience. In these roles, Dickson supported the global sales team in the launch of syringe pumps, led technical product training and application support, reviewed new projects by identifying technical feasibility for new applications, launched new precision fluid delivery platforms, designed a syringe pump, developed test plans, and led various other value-added engineering projects.

Dickson has extensive experience in Design Failure Mode and Effects Analysis (DFMEA), Process Failure Mode Effects Analysis (PFMEA), Advanced Product Quality Planning (APQP), Lean Manufacturing, and sheet metal and die/sand casting design. Dickson holds a Bachelor of Science in Mechanical Engineering.

Robert Morin, Vice President, Commercial Operations at Fluid Metering, states "Dickson's wealth of knowledge in microfluidic application, tech savvy skills and commitment to the highest standards of customer focus makes him and ideal fit for Business Development Manager. We are thrilled Dickson has joined the Commercial Team at Fluid Metering Inc."

About Fluid Metering Inc.

Fluid Metering, Inc. pioneered the first patented valve-less rotating and reciprocating piston metering pump concept delivering pumping excellence and precise fluid control for Laboratory, Industrial, Process and OEM applications. Fluid Metering's Engineering Team incorporates 60 years of OEM design experience to meet specific customer and application requirements with Accuracy, Precision & Reliability!

Learn more at: https://www.fluidmetering.com/

Follow Us
FACEBOOK: https://www.facebook.com/FluidMeteringInc/
TWITTER: https://twitter.com/fluidmetering
YOUTUBE: https://www.youtube.com/user/fmipump1959
LINKEDIN: https://www.linkedin.com/company/fluid-metering-inc-/?viewAsMember=true

Media Contact Information:
Name: Denise Sternbach
Phone: 516-922-6050 xt.113
Denise.Sternbach@fluidmetering.com

Fluid Metering Inc. welcomes Dickson Ong as Business Development Manager - North America. Dickson will be the lead account manager of all North American key OEM accounts and will be responsible for growing business in North America by building relationships with FMI channel partners and strategic OEMs in the Life Science markets.

Related link: https://www.fluidmetering.com/